Externalization of Mitochondrial PDCE2 on Irradiated Endothelium as a Target for Radiation-Guided Drug Delivery and Precision Thrombosis of Pathological Vasculature

• Published in: International journal of molecular sciences Vol. 23; no. 16; p. 8908
• Main Authors: Faqihi, Fahimeh, Stoodley, Marcus A., McRobb, Lucinda S.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 10.08.2022; MDPI
• Subjects: Antibodies; arteriovenous malformation; Biomarkers; Blood circulation; Blood clots; Cell surface; Conjugates; Drug delivery; Drug dosages; drug targeting; Ectopic expression; endothelial cell; Endothelial cells; Endothelium; Experiments; Fibrin; Ionizing radiation; Mitochondria; PDCE2; Proteins; Pyruvic acid; Radiation; Thrombin; Thrombosis; Tumors
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23168908

Endothelial cells are highly sensitive to ionizing radiation, and exposure leads to multiple adaptive changes. Remarkably, part of this response is the translocation of normally intracellular proteins to the cell surface. It is unclear whether this ectopic expression has a protective or deleterious function, but, regardless, these surface-exposed proteins may provide unique discriminatory targets for radiation-guided drug delivery to vascular malformations or tumor vasculature. We investigated the ability of an antibody–thrombin conjugate targeting mitochondrial PDCE2 (E2 subunit of pyruvate dehydrogenase) to induce precision thrombosis on irradiated endothelial cells in a parallel-plate flow system. Click-chemistry was used to create antibody–thrombin conjugates targeting PDCE2 as the vascular targeting agent (VTA). VTAs were injected into the parallel-plate flow system with whole human blood circulating over irradiated cells. The efficacy and specificity of fibrin-thrombus formation was assessed relative to non-irradiated controls. The PDCE2-targeting VTA dose-dependently increased thrombus formation: minimal thrombosis was induced in response to 5 Gy radiation; doses of 15 and 25 Gy induced significant thrombosis with equivalent efficacy. Negligible VTA binding or thrombosis was demonstrated in the absence of radiation or with non-targeted thrombin. PDCE2 represents a unique discriminatory target for radiation-guided drug delivery and precision thrombosis in pathological vasculature.